Hester Biosciences Ltd Share Price ₹1,953

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Hester Biosciences Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	67	88	70	67	79	82	84	63	82	84	71	77	100
Expenses +	56	73	57	57	63	65	65	58	63	61	59	60	66
Operating Profit	12	14	13	10	16	18	19	5	19	23	12	18	34
OPM %	17%	16%	19%	15%	20%	21%	23%	8%	23%	27%	17%	23%	34%
Other Income +	3	3	6	2	5	2	3	9	-6	3	12	2	2
Interest	1	3	8	2	7	5	6	-4	6	2	2	2	5
Depreciation	5	5	4	4	4	4	4	4	4	4	4	4	6
Profit before tax	8	9	7	6	10	11	12	13	4	20	17	14	25
Tax %	32%	25%	40%	37%	35%	29%	29%	15%	59%	14%	16%	31%	34%
Net Profit +	6	7	4	4	6	7	8	11	2	17	14	9	17
EPS in Rs	5.33	6.90	4.81	4.68	5.82	7.45	9.64	13.71	1.52	19.33	16.99	10.31	18.78

Financials of Hester Biosciences Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	90	101	123	136	178	183	214	235	266	305	311	333
Expenses +	64	67	82	89	110	128	146	175	215	251	250	246
Operating Profit	25	34	41	47	68	55	69	60	51	54	62	87
OPM %	28%	34%	33%	35%	38%	30%	32%	26%	19%	18%	20%	26%
Other Income +	3	1	0	3	7	6	1	14	20	15	8	19
Interest	5	4	4	4	7	7	7	4	9	20	13	11
Depreciation	6	6	7	10	12	13	13	17	21	17	17	19
Profit before tax	18	25	31	36	57	41	50	54	40	32	40	76
Tax %	26%	23%	26%	36%	28%	25%	31%	26%	30%	34%	27%	24%
Net Profit +	13	19	23	23	41	31	35	39	28	21	29	57
EPS in Rs	15.99	22.57	27.68	30.12	48.87	34.29	40.47	46.22	31.30	22.21	32.31	65.41
Dividend Payout %	19%	18%	19%	33%	23%	19%	25%	22%	26%	27%	22%	17%

Financials of Hester Biosciences Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9	9	9	9	9	9	9	9	9	9	9	9
Reserves	76	93	113	132	169	193	220	251	271	283	306	352
Borrowings +	55	59	66	69	90	121	110	228	274	244	213	195
Other Liabilities +	20	25	25	35	32	65	73	74	116	126	126	123
Total Liabilities	160	186	213	244	299	387	411	562	670	662	653	678
Fixed Assets +	60	65	102	110	145	142	133	237	259	240	233	421
CWIP	33	36	21	32	7	74	109	82	149	171	183	0
Investments	0	0	0	0	0	0	0	21	25	30	34	43
Other Assets +	68	85	89	102	148	170	169	222	237	221	203	215
Total Assets	160	186	213	244	299	387	411	562	670	662	653	678

Financials of Hester Biosciences Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	20	19	35	38	47	37	58	9	24	48	65	64
Cash from Investing Activity +	-21	-13	-30	-26	-21	-73	-42	-117	-77	-22	-20	-3
Cash from Financing Activity +	7	-7	2	-11	3	19	-18	112	42	-26	-52	-49
Net Cash Flow	5	-1	6	1	28	-17	-2	3	-12	-0	-7	12
Free Cash Flow	1	5	5	15	24	-36	17	-87	-54	24	44	47
CFO/OP	100%	74%	102%	100%	92%	86%	105%	43%	63%	112%	123%	90%

Financials of Hester Biosciences Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	72	95	79	87	67	116	84	86	109	94	86	105
Inventory Days	431	627	376	505	540	834	452	424	399	288	291	323
Days Payable	68	109	84	100	93	261	204	101	141	98	122	110
Cash Conversion Cycle	434	614	371	491	514	690	332	409	367	284	255	318
Working Capital Days	76	112	90	82	106	104	134	113	88	112	74	54
ROCE %	15%	19%	19%	20%	26%	16%	18%	14%	9%	9%	10%	15%